ESC Premium Access

Q&A - Can you achieve more for your PAH patients? An expert review of key recent data with initial combination therapy.

Presentation

About the speaker

Professor Irene Marthe Lang

Medical University of Vienna, Vienna (Austria)
27 presentations
0 follower

4 more presentations in this session

Introduction - Can you achieve more for your pulmonary arterial hypertension (PAH) patients? An expert review of key recent data with initial combination therapy.

Speaker: Professor I. Lang (Vienna, AT)

Thumbnail

Risk stratification in PAH: are any of our patients really "low risk"?

Speaker: Professor I. Lang (Vienna, AT)

Thumbnail

The importance of reducing hospitalisations in PAH.

Speaker: Professor J. Vachiery (Brussels, BE)

Thumbnail

Can your connective tissue disease-associated PAH patients achieve similar outcomes to your idiopathic PAH patients?

Speaker: Doctor J. Coghlan (London, GB)

Thumbnail

Access the full session

Can you achieve more for your pulmonary arterial hypertension (PAH) patients? An expert review of key recent data with initial combination therapy

Speakers: Professor I. Lang, Professor I. Lang, Professor I. Lang, Professor J. Vachiery, Doctor J. Coghlan
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk